Reddy J, Svoboda D
Am J Pathol. 1973 Mar;70(3):421-38.
Male wild-type mice (Cs(a) strain) were treated with ethyl-alpha-p-chlorophenoxyisobutyrate (CPIB), a hypolipidemic drug which enhances hepatic catalase synthesis and induces rapid and significant increase in the number of microbody (peroxisome) profiles in liver cells. Numerous microbody profiles, several of them appearing in clusters and retaining membranous continuities, were observed in liver cells of CPIB-treated mice. They showed a significant variation in size and configuration, and the presence or absence of the nucleoid or core did not appear to bear any relation to the size or shape of microbody profiles. Nucleoids were encountered frequently in microbody profiles measuring as small as 0.1 mu in diameter. Numerous continuities between two or more anucleoid and/or nucleoid-containing microbody profiles of different sizes and shapes were seen. These findings are inconsistent with the concept that the smaller peroxisomes are the possible precursors or progenitors of their larger counterparts. Detailed examination of numerous electron micrographs revealed irregular dilatations and tortuosities of the endoplasmic reticulum (ER) containing electron-opaque peroxisomal material displaying the characteristic appearance of matrix and usually containing irregular cores. Transitions of rough ER to smooth ER in which microbody proteins accumulated were also apparent. Numerous continuities between several microbody profiles and continuities between microbody profiles and ER are interpreted as accumulations of peroxisomal proteins in dilated tortuous channels of ER. These observations strongly suggest that the microbody proteins constitute a common pool, circulating constantly in the dilated ER channels. The size, shape and number of microbody profiles appear to reflect the amount of peroxisomal proteins present in the pool. These observations clearly suggest that the microbodies do not exist as individual entities.
雄性野生型小鼠(Cs(a)品系)用乙基-α-对氯苯氧基异丁酸酯(CPIB)进行处理,CPIB是一种降血脂药物,可增强肝脏过氧化氢酶的合成,并诱导肝细胞中微体(过氧化物酶体)轮廓数量迅速且显著增加。在接受CPIB处理的小鼠肝细胞中观察到大量微体轮廓,其中一些呈簇状出现并保持膜连续性。它们在大小和形态上有显著差异,类核或核心的有无似乎与微体轮廓的大小或形状没有任何关系。在直径小至0.1微米的微体轮廓中经常遇到类核。可以看到不同大小和形状的两个或更多无类核和/或含类核的微体轮廓之间有许多连续性。这些发现与较小的过氧化物酶体是较大过氧化物酶体的可能前体或祖细胞的概念不一致。对大量电子显微镜照片的详细检查显示,含有电子不透明过氧化物酶体物质的内质网(ER)出现不规则扩张和扭曲,这些物质呈现出基质的特征外观,通常含有不规则的核心。粗糙内质网向光滑内质网的转变也很明显,其中积累了微体蛋白。几个微体轮廓之间的许多连续性以及微体轮廓与内质网之间的连续性被解释为过氧化物酶体蛋白在内质网扩张扭曲通道中的积累。这些观察结果强烈表明,微体蛋白构成了一个共同的池,在扩张的内质网通道中不断循环。微体轮廓的大小、形状和数量似乎反映了池中过氧化物酶体蛋白的含量。这些观察结果清楚地表明,微体并非作为个体实体存在。